vimarsana.com
Home
Live Updates
Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech : vimarsana.com
Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech
Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among the general population.
Related Keywords
Delhi ,
India ,
Bharat ,
,
World Health Organization ,
India Institute Of Medical Sciences ,
Covaxin Meets ,
For Delta ,
Shows Lancet Study ,
Bharat Biotech ,
Lancet Infectious Diseases ,
Hyderabad Based Bharat Biotech ,
All India Institute ,
Medical Sciences ,
Coronavirus ,
Covaxin ,
vimarsana.com © 2020. All Rights Reserved.